Spheroid cultures of CAFs transfected with Endo180 (Mrc2) siRNAs showed reduced viability and altered contractility; and systemic deletion of Mrc2 significantly reduced tumor burden and metastatic progression of 4T1 mouse mammary carcinoma cells in vivo [161]. The gene discussed is MRC2; the disease is breast carcinoma.